drugset / Trial / NCT04845061
Evaluating the Outcome of Cardio Selective beta1- Blockers Use in Patients With Copd
RandomizedCrossoverSingle-blindPrevention
Summary
To Evaluate the Outcome of cardio selective beta1 (β1-) blockers use in patients with chronic obstructive pulmonary disease. Patient education about the COPD and their medications.
Timeline
- Start
- 2021-10-01
- Primary completion
- 2021-12-15
- Completion
- 2022-01-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Nebivolol | Other / unclassified | 5 mg | — |